ISOTOPEN-LABORATORIUM DR. SAUERWEIN GMBH – Trademark Portfolio
Entity Type: 16
ISOTOPEN-LABORATORIUM DR. SAUERWEIN GMBH holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include GAMMAMED. The owner is based in HAAN/RHEINL..
POSTFACH 1354
BERGISCHE STRASSE 16
HAAN/RHEINL. 1 , DE
Showing of trademarks Trademarks
Trademark Classifications
ISOTOPEN-LABORATORIUM DR. SAUERWEIN GMBH's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does ISOTOPEN-LABORATORIUM DR. SAUERWEIN GMBH have?
ISOTOPEN-LABORATORIUM DR. SAUERWEIN GMBH has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.
What trademark classes does ISOTOPEN-LABORATORIUM DR. SAUERWEIN GMBH file in?
ISOTOPEN-LABORATORIUM DR. SAUERWEIN GMBH files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are ISOTOPEN-LABORATORIUM DR. SAUERWEIN GMBH's most well-known trademarks?
ISOTOPEN-LABORATORIUM DR. SAUERWEIN GMBH's registered trademark portfolio includes well-known marks such as GAMMAMED. These are among 1 currently registered trademark in the portfolio.
What is ISOTOPEN-LABORATORIUM DR. SAUERWEIN GMBH's trademark registration success rate?
ISOTOPEN-LABORATORIUM DR. SAUERWEIN GMBH has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.